These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8968692)

  • 21. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
    Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
    J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
    Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
    Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A carcinogenic bioassay of certain roofing materials.
    Emmett EA; Bingham EM; Barkley W
    Am J Ind Med; 1981; 2(1):59-64. PubMed ID: 7349035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensating lung cancer patients occupationally exposed to coal tar pitch volatiles.
    Armstrong B; Thériault G
    Occup Environ Med; 1996 Mar; 53(3):160-7. PubMed ID: 8704856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study on the carcinogenic effect of common coal tar and of a new synthetic tar].
    Hilfrich J; Mohr U
    Arch Dermatol Forsch; 1972; 242(2):176-8. PubMed ID: 5024626
    [No Abstract]   [Full Text] [Related]  

  • 26. Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar.
    Godschalk RW; Ostertag JU; Moonen EJ; Neumann HA; Kleinjans JC; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):767-73. PubMed ID: 9752984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The carcinogenic effect of Locacorten tar oil under experimental conditions].
    Linnik AB
    Vestn Dermatol Venerol; 1970 Dec; 44(12):32-6. PubMed ID: 5516663
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
    Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
    Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer risk estimation for mixtures of coal tars and benzo(a)pyrene.
    Gaylor DW; Culp SJ; Goldstein LS; Beland FA
    Risk Anal; 2000 Feb; 20(1):81-5. PubMed ID: 10795341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application.
    Schoket B; Hewer A; Grover PL; Phillips DH
    Carcinogenesis; 1988 Jul; 9(7):1253-8. PubMed ID: 3383342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should coal tar products carry cancer warnings?
    Zackheim HS
    Cutis; 2004 May; 73(5):333-4. PubMed ID: 15186048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption of polycyclic aromatic hydrocarbons through human skin: differences between anatomical sites and individuals.
    VanRooij JG; De Roos JH; Bodelier-Bade MM; Jongeneelen FJ
    J Toxicol Environ Health; 1993 Apr; 38(4):355-68. PubMed ID: 8478978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The carcinogenicity and mutagenicity of therapeutic coal tar--a perspective.
    Bickers DR
    J Invest Dermatol; 1981 Aug; 77(2):173-4. PubMed ID: 7276611
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
    Clonfero E; Jongeneelen F; Zordan M; Levis AG
    IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of skin cancers in patients with atopic dermatitis treated with coal tar. A 25-year follow-up study.
    Maughan WZ; Muller SA; Perry HO; Pittelkow MR; O'Brien PC
    J Am Acad Dermatol; 1980 Dec; 3(6):612-5. PubMed ID: 7204678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PAHs exposure and occupational health risk assessment of workers in coal tar pitch factory].
    Lu CD; Sun XC; Zhang LS; Zhang F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Jan; 36(1):38-41. PubMed ID: 29495178
    [No Abstract]   [Full Text] [Related]  

  • 37. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benzo(a)pyrene and the carcinogenic effect of coal tar].
    Turusov VS; Kosoĭ KKh; Parfenov IuD
    Vopr Onkol; 1987; 33(10):62-7. PubMed ID: 3686910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health effects of coal mining and combustion: carcinogens and cofactors.
    Falk HL; Jurgelski W
    Environ Health Perspect; 1979 Dec; 33():203-26. PubMed ID: 540618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To BaP or not to BaP? That is the question.
    Goldstein LS
    Environ Health Perspect; 2001 Aug; 109(8):A356-7. PubMed ID: 11564626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.